MRND — IQ U.S. Mid Cap R&D Leaders ETF

Data updated: 2023-12-20

MRND — IQ U.S. Mid Cap R&D Leaders ETF. United States Mid Cap Growth Equity · $4.01M AUM · 0.16% expense ratio. Holdings, fees, performance and SEC filings.

MRND Fund Overview

MRND — IQ U.S. Mid Cap R&D Leaders ETF is a US ETF managed by New York Life Investments ETF Trust, categorised as United States Mid Cap Growth Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

Type: US ETF
Manager: New York Life Investments ETF Trust
Category: United States Mid Cap Growth Equity
Assets under management: $4.01M
1-year return: -1.1%
Ticker: MRND
SEC CIK: 0001415995
SEC series ID: S000074746
Share class ID: C000232899

MRND Investment Objective and Strategy

IQ U.S. Mid Cap R&D Leaders ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by New York Life Investments ETF Trust.

Investment objective

The Fund seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the IQ U.S. Mid Cap R&D Leaders Index (the Underlying Index).

Principal investment strategy

The Fund employs a passive management or indexing investment approach designed to track the performance of the Underlying Index, which was developed by IndexIQ LLC (IndexIQ), an affiliate of IndexIQ Advisors LLC, the Funds investment advisor (the Advisor). The Underlying Index seeks to provide exposure to innovative companies by investing in the equities of US mid cap companies that have high research and development (R&D) spending. As of June 30, 2023, the market capitalization range of the Underlying Index was approximately $641 million to $66.29 billion. As of June 30, 2023, the primary sectors within the Underlying Index were consumer discretionary, health care and information technology. The Fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its Underlying Index.

The securities eligible for inclusion in the Underlying Index are those securities included in the Russell Midcap Index. The Underlying Index consists of the 100 eligible component securities with the highest dollar amount of research and development spending during the previous year. Research and development spending includes expenditures on research and development intended for the development of concepts or ideas for new products or services by which the issuer can increase revenues. Securities selected for inclusion in the Underlying Index are weighted based on the issuers total R&D spending relative to the other securities selected for inclusion in the Underlying Index, subject to a maximum weight at the time of rebalance of the greater of? (i) 5%, or (ii) the weight of a components issuer in the Russell Mid Cap Growth Index plus 2% (Component Weight Cap).

To the extent a component would exceed the Component Weight Cap at the time of rebalance, the excess percentage is allocated proportionately among the other components of the Underlying Index. The Underlying Index is reconstituted and rebalanced quarterly. Additionally, at the time of rebalance, the Underlying Index limits the maximum weight of all securities within each sector to the greater of? (i) 30% of the Underlying Index, or (ii) the weight of the sector in the Russell Mid Cap Growth Index plus 5% (Sector Weight Cap). To the extent the securities within a sector would exceed the Sector Weight Cap at the time of rebalance, the excess percentage is allocated proportionately among securities within the other sectors of the Underlying Index. The Fund generally will invest in all of the securities that comprise its Underlying Index in proportion to their weightings in the Underlying Index.

The Fund has adopted a policy to invest, under normal circumstances, at least 80% of the value of its assets (net assets plus the amount of any borrowings for investment purposes) in securities of U.S. mid-capitalization issuers. The Underlying Index may include as a component one or more ETFs advised by the Advisor (Affiliated ETFs) and the Fund will typically invest in any Affiliated ETF included in the Underlying Index. The Fund also may invest in Affiliated ETFs that are not components of the index if such an investment will help the Fund track the Underlying Index.

MRND Performance

Total returns for MRND (as of 2026-10-01), from SEC filings.

Period	Total return
1 year	-1.1%

MRND Risk Information

Risk metrics for MRND, derived from monthly returns in SEC filings.

1-year volatility (annualised): 22.1%

MRND Costs and Fees

MRND costs about $16 per $10,000 invested per year in fund expenses.

Net expense ratio: 0.16%
Gross expense ratio: 0.17%
Portfolio turnover: 54%
Brokerage commissions: 8.52 bps of average net assets (SEC N-CEN)

MRND Cashflows

Over the 12 months to 2023-10, IQ U.S. Mid Cap R&D Leaders ETF had net inflows of $0, from monthly SEC N-PORT filings.

Month	Net flow
2023-10	$0
2023-09	$0
2023-08	$0
2023-07	$0
2023-06	$0
2023-05	$0

MRND Debt Constituents

No individual debt constituents are reported in IQ U.S. Mid Cap R&D Leaders ETF's latest SEC N-PORT filing.

MRND Prospectus and SEC Filings

Official IQ U.S. Mid Cap R&D Leaders ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

Related Funds

Other United States Mid Cap Growth Equity funds tracked on ABC INVEST:

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.